REFERENCES
- Simonneau G, Galie N, Rubin LJ, Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12)(Suppl. S):5S–12S.
- Zuber JP, Calmy A, Evison JM, Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis. 2004;38(8):1178–1185.
- Derchi G, Fonti A, Forni GL, Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1999;138(2, Pt 1):384.
- Grisaru D, Rachmilewitz EA, Mosseri M, Cardiopulmonary assessment in β-thalassemia major. Chest. 1990;98(5):1138–1142.
- Aessopos A, Farmakis D, Hatziliami A, Cardiac status in well-treated patients with thalassemia major. Eur J Haematol. 2004;73(5):359–366.
- Derchi G, Formisano F, Lamagna M, Incidence of pulmonary hypertension in hemoglobinopathic patients without left ventricular dysfunction. Blood. 2005;106(11) ( abstract).
- Nunes H, Humbert M, Sitbon O, Prognostic factors for survival in human immunodeficiency virus associated pulmonary arterial hypertension. Am J Respire Crit Care Med. 2003;167(10):1433–1439.
- Marecki JC, Cool CD, Beckey VE, HIV-1 Nef protein is present a the site of plexiform lesions in patients with HIV-related pulmonary hypertension and induces a program altered endothelial cell growth and survival in vitro. Proc Am Thorac Soc. 2006;3:A476.
- Cool CD, Rai PR, Yeager ME, Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med. 2003;349(12):1113–1122.
- Gutiérrez F, Masia M, Padilla S, Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: a clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension? J Clin Virol. 2006;37(2):79–82.
- Eddahibi S, Humbert M, Sediame S, Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effects of prostacyclin therapy. Am J Respir Crit Care Med. 2000;162(4, Pt 1):1493–1499.
- Aoki Y, Jaffe ES, Chang Y, Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 1999;93(12):4034–4043.
- Jison ML, Gladwin MT. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. Am J Respir Crit Care Med. 2003;168(1):3–4.
- Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2005; 51–57.
- Morris CR, Kato GJ, Poljakovic M, Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension and mortality in sickle cell disease. JAMA. 2005;294(1):81–90.
- Rother RP, Bell L, Hillmen P, The clinical sequeleae of intravascular hemolysis and extracellular plasma haemoglobin: a novel mechanism of human disease. JAMA. 20056;293(13):1653–1662.
- Atichartakarn V, Likittanasombat K, Chuncharunee S, Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders. Int J Hematol. 2003;78(2):139–145.
- Zakynthinos E, Vassilakopoulos T, Kaltsas P, Pulmonary hypertension, interstitial lung fibrosis, and lung iron deposition in thalassemia major. Thorax. 2001;56(9):737–739.
- Du ZD, Roguin N, Milgram E, Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134(3):532–537.
- Barnett CF, Hsue PY, Machado RF. Pulmonary hypertension. An increasingly recognized complication of hereditary haemolytic anemias and HIV infection. JAMA. 200823;299(3):324–331.
- Aliyu ZY, Kato GJ, Taylor J, 4th. Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology and management. Am J Hematol. 2008;83(1):63–70.
- Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351(14):1425–1436.
- Derchi G, Forni GL, Formisano F, Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica. 2005;90(4):452–458.
- Lin EE, Gladwin MT, Machado RF. Pulmonary hypertension in patients with hemoglobinopathies: could a mechanism for dysfunction provide an avenue for novel therapeutics? Haematologica. 2005;90(4):441–443.